Obesity

The exam rarely just asks you to label a BMI; it tests what you do with it and which intervention level fits the scenario. The classic “tell” is a stalled, frustrated client where the right answer is to assess readiness and explore the client’s own reasons to change before teaching or planning—NCLEX rewards the motivational-interviewing stance, not advice-giving. Expect realistic goals as a correct option: 5–10% weight loss over ~6 months meaningfully lowers blood pressure and A1C, and a safe pace is 1–2 lb/week. Pharmacotherapy (now commonly GLP-1 agonists like semaglutide) is generally an add-on at BMI ≥30, or ≥27 with a comorbidity; current ASMBS/IFSO guidance considers bariatric surgery at BMI ≥35 regardless of comorbidity, or ≥30 with metabolic disease (many question banks still teach the older ≥40, or ≥35 with comorbidity NIH cutoffs).

The trap is mixing up the related concepts. Exercise is one modifiable behavior, but for weight loss diet usually outdrives activity—don’t pick “exercise alone.” Counseling is the method (the how), whereas prevention is the framing: treating existing obesity is tertiary prevention, while keeping a normal-weight client from gaining is primary. Misclassifying that level is the most common miss.